Good day and thank you for your presentations.
We heard that there are 150 different types of cancer. How many cancer-fighting drugs would have to be reviewed under the new JODR initiative in order for you to be satisfied? Some of you have doubts about whether this new approach will be effective, because not enough new drugs are being approved. Is the problem a lack of resources, reviews or experts?
Quebec carries out its own drug review. I can't say if its resources are comparable, but we are here to try and sort this all out and to ascertain if the JODR approach is indeed effective.
Can you tell us how many drugs you would like to see reviewed? In your opinion, will this new process be adequately funded? Will there be sufficient resources, in terms of reviewers and experts, to get the job done?